Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Vitamin D Supplementation for Reducing or Preventing Fatigue in Colorectal Cancer Patients (VICTORIA)
2024-515420-37-01Phase 3Completed
- Sponsor
- German Cancer Research Center
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC) and cancer-related fatigue (CRF) comparing Vitamin D3 supplementation with Placebo (2 arms). Primary endpoint: FACIT-F fatigue subscale mean difference at trial week 13–16. Started Jan 2025; status: completed.
02
Drugs
vitamin d
03
Conditions
colorectal cancer (CRC)cancer-related fatigue (CRF)
Beyond the preview
Go deeper on 2024-515420-37-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515420-37-01.